期刊文献+

洛赛克联合西沙比利治疗反流性食管炎45例临床观察 被引量:3

洛赛克联合西沙比利治疗反流性食管炎45例临床观察
下载PDF
导出
摘要 目的:观察洛赛克联合西沙比利治疗反流性食管炎的疗效。方法:回顾分析2007年1月~2008年12月收治的90例反流性食管炎患者,随机分为治疗组和对照组各45例。治疗组用洛赛克20mg,2次/日;加用西沙比利10mg,3次/日,饭前15~30分钟口服。对照组单独服用与治疗组同厂家、同批号的西沙比利10mg/次,每日3次,饭前15~30分钟口服。疗程4周。结果:治疗4周后两组临床症状均有所缓解,治疗组总有效率明显高于对照组(P<0.05)。治疗组患者胃镜下食管炎愈合有效率与对照组差异有统计学意义(P<0.05)。结论:洛赛克与西沙比利联合使用治疗反流性食管炎疗效优于单独使用西沙比利。 Purpose: Observe curative effect of Losee and Cisapride in reflux esophagitis. Method:Review and analyze 90 cases of reflux esophagitis treated in our hospital from January 2007 to December 2008, and randomly divide them into treatment group and control group with 45 cases in each group. Use 20mg Losec for the treatment group at 2 times/d and 10mg Cisapride at 3 times/d. Take them orally before meals; 15 -30 mi- nautes before meals, the control group only independently take the Cisapride orally at 3 times/d and 10mg/times. The treatment lasts four weeks. Result : after 4 - week treat- ment, clinical symptoms of the two groups are relieved. The total efficiency of the treat- ment group is evidently higher than the con- trol group ( P 〈 0. 05 ). There is statisti-cahneaning in difference of the esophagitis healing effectiveness ratio under the gastro- scope between patients of the treatment group and the control grouip ( P 〈 0. 05 ). Conchlsion: Curative effect of l,osee and Cisapride in retlux esophagitis exceeds that of Cisapride.
作者 钟荣
出处 《中国社区医师(医学专业)》 2009年第19期48-49,共2页
关键词 反流性食管炎 联合应用 洛赛克 西沙比利 reflux esophagitis joint application losee eisapride
  • 相关文献

参考文献5

二级参考文献5

共引文献439

同被引文献16

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部